查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1308235

2023-2028年按产品类型（心脏标志物检测、分析仪）、终端用户（医院、诊断实验室及其他）和地区分類的心脏PoC检测设备市场

Cardiac PoC Testing Devices Market by Product Type (Cardiac Markers Test, Analyzers), End User (Hospitals, Diagnostic Laboratories, and Others), and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格
简介目录

市场概述：

2022年，全球心脏PoC测试设备市场规模达到17.5亿美元。展望未来，IMARC集团预计到2028年，该市场规模将达到24.7亿美元，2023-2028年间的年复合增长率（CAGR）为6.10%。烟草消费过多导致心血管疾病发病率上升；检测脑钠肽，激酶，合成肌钙蛋白和乳酸脱氢酶同工酶的需求上升；以及医疗行业的蓬勃发展是推动市场发展的一些关键因素。

心脏护理点（PoC）检测设备是创新的便携式医疗仪器，旨在快速准确地诊断心脏疾病。它们结构紧凑、使用方便，可提供实时结果，使医生能够就患者护理做出迅速、明智的决定。它们为医护人员提供了在患者床旁进行诊断测试的能力，消除了对实验室测试的需求，缩短了关键心脏评估的周转时间。它们能在几分钟内提供准确可靠的结果，从而提高临床工作流程的效率。它们有助于进行各种诊断测试，包括心脏生物标志物分析、凝血监测、胆固醇分析和电解质测量。它们有助于立即获得检测结果，从而更有效地分流病人，减少急诊科的拥挤程度，优化资源分配。由于减少了对集中实验室的依赖，最大限度地降低了与样本运输、实验室人员和基础设施相关的成本，全球对心脏PoC检测设备的需求正在上升。

心脏PoC检测设备市场趋势：

目前，由于过度吸烟和饮酒导致的心血管疾病发病率上升是促进市场增长的关键因素之一。此外，全球使用心脏PoC检测设备检测心肌梗死和冠状动脉综合征的人数也在增加。这一点以及蓬勃发展的医疗行业为市场增长提供了支持。此外，越来越多的人使用这些设备来鉴定脑钠肽，激酶，合成肌钙蛋白，以及心力衰竭时产生的乳酸脱氢酶同工酶，这些都对市场产生了积极的影响。除此以外，主要企业正致力于推出基于智能手机的心血管疾病检测。他们还在开发技术先进的心脏生物标志物分析仪，从而促进了市场的增长。此外，对心脏分析仪的需求也在增加，因为它们有软件提供内部标准，以考虑到测试中固有的膜变异性，并集成了LCD显示屏，以方便用户和提高视觉清晰度。再加上分析仪能够量化全血、血清和血浆中生物标志物的浓度，有助于临床诊断，这些都推动了市场的增长。此外，PoC检测设备技术的不断进步也提供了一个有利的市场前景。

本报告回答的关键问题

  • 到目前为止，全球心脏PoC检测设备市场的表现如何？
  • 全球心脏PoC检测设备市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球心脏PoC检测设备市场的影响是什么？
  • 哪些是主要的区域市场？
  • 哪些国家的心脏PoC检测设备市场最具吸引力？
  • 基于产品类型的市场细分是什么？
  • 哪种产品类型在心脏PoC检测设备市场最具吸引力？
  • 基于终端用户的市场划分是怎样的？
  • 哪个是心脏PoC检测设备市场最具吸引力的终端用户？
  • 全球心脏PoC检测设备市场的竞争结构是什么？
  • 全球心脏PoC检测设备市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围和方法

  • 研究目标
  • 利益相关者
  • 数据来源
    • 第一手资料
    • 二手资料
  • 市场评估
    • 自下而上法
    • 自上而下法
  • 预测方法

第三章：执行摘要

第四章 : 简介

  • 概述
  • 主要行业趋势

第5章：全球心脏PoC检测设备市场

  • 市场概述
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：按产品类型分類的市场细分

  • 心脏标志物检测
    • 市场趋势
    • 主要细分市场
    • 心肌肌钙蛋白（cTn）检测试剂盒
    • 肌红蛋白检测
    • 肌酸激酶同工酶（CK-MB）检测试剂盒
    • 复合检测试剂盒
    • 脑钠肽 (BNP) 检测试剂盒
    • 市场预测
  • 分析仪
    • 市场趋势
    • 市场预测

第七章 ：按终端用户分類的市场

  • 医院
    • 市场趋势
    • 市场预测
  • 诊断实验室
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第八章：按地区分類的市场细分

  • 北美洲
    • 美国
    • 市场趋势
    • 市场预测
    • 加拿大
    • 市场趋势
    • 市场预测
  • 亚太地区
    • 中国
    • 市场趋势
    • 市场预测
    • 日本市场
    • 市场趋势
    • 市场预测
    • 印度市场
    • 市场趋势
    • 市场预测
    • 韩国
    • 市场趋势
    • 市场预测
    • 澳大利亚
    • 市场趋势
    • 市场预测
    • 印尼
    • 市场趋势
    • 市场预测
    • 其他市场
    • 市场趋势
    • 市场预测
  • 欧洲
    • 德国
    • 市场趋势
    • 市场预测
    • 法国
    • 市场趋势
    • 市场预测
    • 英国
    • 市场趋势
    • 市场预测
    • 意大利市场
    • 市场趋势
    • 市场预测
    • 西班牙
    • 市场趋势
    • 市场预测
    • 俄罗斯
    • 市场趋势
    • 市场预测
    • 其他市场
    • 市场趋势
    • 市场预测
  • 拉丁美洲
    • 巴西市场
    • 市场趋势
    • 市场预测
    • 墨西哥市场
    • 市场趋势
    • 市场预测
    • 其他市场
    • 市场趋势
    • 市场预测
  • 中东和非洲
    • 市场趋势
    • 各国市场细分
    • 市场预测

第九章：驱动因素、限制因素和机会

  • 驱动因素
  • 驱动因素
  • 限制因素
  • 机会

第10章：价值链分析

第十一章 ：波特五力分析

  • 五力分析概述
  • 买家议价能力
  • 供应商议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十二章 ：价格分析

第十三章 ：竞争格局

  • 市场结构
  • 主要竞争者
  • 主要竞争者简介
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Financials
    • SWOT Analysis
    • ACON Laboratories Inc.
    • Company Overview
    • Product Portfolio
    • Alfa Scientific Designs Inc.
    • Company Overview
    • Product Portfolio
    • Bio-Rad Laboratories Inc.
    • Company Overview
    • Product Portfolio
    • Financials
    • SWOT Analysis
    • Danaher Corporation
    • Company Overview
    • Product Portfolio
    • Financials
    • SWOT Analysis
    • F. Hoffmann-La Roche AG
    • Company Overview
    • Product Portfolio
    • Financials
    • LifeSign LLC
    • Company Overview
    • Product Portfolio
    • Nano-Ditech Corporation
    • Company Overview
    • Product Portfolio
    • Nexus-Dx Inc.
    • Company Overview
    • Product Portfolio
简介目录
Product Code: SR112023A7971

Market Overview:

The global cardiac PoC testing devices market size reached US$ 1.75 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.47 Billion by 2028, exhibiting a growth rate (CAGR) of 6.10% during 2023-2028. The growing prevalence of cardiovascular diseases due to excessive consumption of tobacco; rising need to detect brain natriuretic peptides, kinase, synthesizing troponin, and lactate dehydrogenase isoenzymes; and the thriving medical industry represent some of the key factors driving the market.

Cardiac point-of-care (PoC) testing devices are innovative and portable medical instruments designed for the rapid and accurate diagnosis of cardiac conditions. They are compact, user-friendly, and offer real-time results, enabling physicians to make prompt and informed decisions about patient care. They provide healthcare professionals with the ability to conduct diagnostic tests at the bedside of patients, eliminate the need for laboratory-based testing, and reduce turnaround times for critical cardiac assessments. They enhance the efficiency of clinical workflows by delivering accurate and reliable results within minutes. They assist in performing a variety of diagnostic tests, including cardiac biomarker analysis, coagulation monitoring, cholesterol profiling, and electrolyte measurement. They aid in obtaining immediate test results that facilitate more efficient patient triage, reduce overcrowding in emergency departments, and optimize resource allocation. As they minimize costs associated with sample transportation, lab personnel, and infrastructure by reducing the reliance on centralized laboratories, the demand for cardiac PoC testing devices is rising worldwide.

Cardiac PoC Testing Devices Market Trends:

At present, the rising prevalence of cardiovascular diseases due to the excessive consumption of tobacco and alcohol represents one of the crucial factors bolstering the growth of the market. Moreover, there is an increase in the utilization of cardiac PoC testing devices to detect myocardial infarction and coronary syndromes around the world. This, along with the thriving medical industry, is supporting the growth of the market. In addition, the growing employment of these devices to identify brain natriuretic peptides, kinase, synthesizing troponin, and lactate dehydrogenase isoenzymes that are generated during heart failure is positively influencing the market. Besides this, key players are focusing on launching smartphone-based tests for cardiovascular diseases. They are also developing technologically advanced cardiac biomarker analyzers, which is bolstering the growth of the market. Additionally, there is a rise in the demand for cardiac analyzers, as they have software to provide an internal standard to account for membrane variability that is intrinsic to tests and integrated LCD displays for user convenience and visual clarity. This, coupled with the ability of analyzers to quantify the concentration of biomarkers in whole blood, serum, and plasma, which helps in clinical diagnosis, is impelling the growth of the market. Furthermore, the growing technological advancements in PoC testing devices are offering a favorable market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global cardiac PoC testing devices market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product type and end user.

Product Type Insights:

Cardiac Markers Test

Cardiac Troponin (cTn) Test

Myoglobin Test

Creatine Kinase MB Isoenzyme (CK-MB) Test

Combinational Test Kits

Brain Natriuretic Peptide (BNP) Test

Analyzers

The report has provided a detailed breakup and analysis of the cardiac PoC testing devices market based on the product type. This includes cardiac markers test [cardiac troponin (cTn) test, myoglobin test, creatine kinase MB isoenzyme (CK-MB) test, combinational test kits, and brain natriuretic peptide (BNP) test] and analyzers. According to the report, analyzers represented the largest segment.

End User Insights:

Hospitals

Diagnostic Laboratories

Others

A detailed breakup and analysis of the cardiac PoC testing devices market based on the end user has also been provided in the report. This includes hospitals, diagnostic laboratories, and others. According to the report, diagnostic laboratories accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for cardiac PoC testing devices. Some of the factors driving the North America cardiac PoC testing devices market included the growing cardiovascular burden among the population, increasing healthcare expenditure, rising geriatric population, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global cardiac PoC testing devices market. Detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, ACON Laboratories Inc., Alfa Scientific Designs Inc., Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche AG, LifeSign LLC, Nano-Ditech Corporation, Nexus-Dx Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global cardiac PoC testing devices market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global cardiac PoC testing devices market?
  • What is the impact of each driver, restraint, and opportunity on the global cardiac PoC testing devices market?
  • What are the key regional markets?
  • Which countries represent the most attractive cardiac PoC testing devices market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the cardiac PoC testing devices market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the cardiac PoC testing devices market?
  • What is the competitive structure of the global cardiac PoC testing devices market?
  • Who are the key players/companies in the global cardiac PoC testing devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cardiac PoC Testing Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Cardiac Markers Test
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Cardiac Troponin (cTn) Test
      • 6.1.2.2 Myoglobin Test
      • 6.1.2.3 Creatine Kinase MB Isoenzyme (CK-MB) Test
      • 6.1.2.4 Combinational Test Kits
      • 6.1.2.5 Brain Natriuretic Peptide (BNP) Test
    • 6.1.3 Market Forecast
  • 6.2 Analyzers
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostic Laboratories
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 ACON Laboratories Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Alfa Scientific Designs Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Bio-Rad Laboratories Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Danaher Corporation
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 F. Hoffmann-La Roche AG
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 LifeSign LLC
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Nano-Ditech Corporation
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Nexus-Dx Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.